KRAS and neoplasm: Moreover, we detected 15 gene amplifications in six different tumor specimens, including AR, CCND1 (n = 2), FGF19 (n = 2), FGF3 (n =2), KRAS (n = 2), MYC (n = 2), CCND3, CCNE1, CDK6, and RICTOR.